To Be in Remission or in Corticosteroid-free Remission: That Is the Question for Women With Inflammatory Bowel Disease at Conception
Inflamm Bowel Dis
.
2023 Jun 1;29(6):e20-e21.
doi: 10.1093/ibd/izad023.
Authors
Reiko Kunisaki
1
2
,
Aya Ikeda
1
2
,
Katsuki Yaguchi
1
2
,
Misa Onishi
1
2
,
Shunsuke Shibui
1
2
,
Daisuke Nishida
1
2
,
Akira Madarame
1
,
Kenichiro Toritani
1
,
Yoshinori Nakamori
1
2
,
Masafumi Nishio
1
2
,
Tsuyoshi Ogashiwa
1
2
,
Ayako Fujii
1
,
Hideaki Kimura
1
,
Ryoichi Suzuki
3
,
Shigeru Aoki
4
,
Shin Maeda
2
Affiliations
1
Inflammatory Bowel Disease Center, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan.
2
Department of Gastroenterology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan.
3
Kannai-Suzuki Clinic, 3-63-1 Aioi-cho, Naka-ku, Yokohama 231-0012, Japan.
4
Perinatal Center for Maternity and Neonates, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Japan.
PMID:
36880427
DOI:
10.1093/ibd/izad023
No abstract available
Publication types
Editorial
Comment
MeSH terms
Adrenal Cortex Hormones / therapeutic use
Colitis, Ulcerative*
Crohn Disease*
Female
Humans
Inflammatory Bowel Diseases* / drug therapy
Pregnancy
Pregnant Women
Substances
Adrenal Cortex Hormones